Literature DB >> 14699456

Association of clinical signs and symptoms with bacterial findings in acute otitis media.

Arto A I Palmu1, Elja Herva, Heljä Savolainen, Pekka Karma, P Helena Mäkelä, Terhi M Kilpi.   

Abstract

In acute otitis media (AOM), a means of prediction of the bacterial pathogen based on symptoms and signs would be valuable in selecting appropriate antimicrobial treatment. Children in the control arm (n=831) in the Finnish Otitis Media Vaccine Trial were prospectively observed in a study clinic setting from the age of 2 to 24 months. In patients with AOM, myringotomy with aspiration was performed, and middle ear fluid samples were cultured for bacterial pathogens. Symptoms and signs of respiratory infections were thoroughly recorded. Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae were the most common bacterial pathogens. Pneumococcal AOM was associated with more-severe AOM characterized by fever and earache. AOM due to H. influenzae was associated with eye symptoms and findings. Accurate prediction of a bacterial cause of infection based on symptoms and signs of AOM was not possible, but a specific cause was predicted in some situations, with a high probability of applicability to clinical practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14699456     DOI: 10.1086/380642

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  32 in total

1.  Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis.

Authors:  Nadja Heiniger; Rolf Troller; Patricia Stutzmann Meier; Christoph Aebi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 2.  Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany.

Authors:  M van der Linden; R R Reinert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-30       Impact factor: 3.267

3.  Moraxella catarrhalis AcrAB-OprM efflux pump contributes to antimicrobial resistance and is enhanced during cold shock response.

Authors:  Violeta Spaniol; Sara Bernhard; Christoph Aebi
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

4.  Clinical significance of serum S100A12 in acute otitis media in young children.

Authors:  Keyi Liu; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2012-03       Impact factor: 2.129

5.  Update on acute otitis media in children younger than 2 years of age.

Authors:  Colin J McWilliams; Ran D Goldman
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

6.  A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age.

Authors:  Nicole Le Saux; Isabelle Gaboury; Marian Baird; Terry P Klassen; Johnna MacCormick; Colline Blanchard; Carrol Pitters; Margaret Sampson; David Moher
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

Review 7.  Acute otitis media with spontaneous tympanic membrane perforation.

Authors:  N Principi; P Marchisio; C Rosazza; C S Sciarrabba; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

Review 8.  Differentiating Acute Otitis Media and Acute Mastoiditis in Hospitalized Children.

Authors:  Anu Laulajainen-Hongisto; Antti A Aarnisalo; Jussi Jero
Journal:  Curr Allergy Asthma Rep       Date:  2016-10       Impact factor: 4.806

9.  Higher serum levels of interleukin 10 occur at onset of acute otitis media caused by Streptococcus pneumoniae compared to Haemophilus influenzae and Moraxella catarrhalis.

Authors:  Keyi Liu; Ravinder Kaur; Anthony Almudevar; Michael E Pichichero
Journal:  Laryngoscope       Date:  2013-02-12       Impact factor: 3.325

10.  Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece.

Authors:  Ioannis Katsarolis; Garyphallia Poulakou; Antonios Analitis; Irini Matthaiopoulou; Emmanuel Roilides; Charalampos Antachopoulos; Dimitrios A Kafetzis; Georgios L Daikos; Regina Vorou; Christina Koubaniou; Ioannis Pneumatikos; Georgios Samonis; Vasiliki Syriopoulou; Helen Giamarellou; Kyriaki Kanellakopoulou
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.